Year: 2022
Type: dissertation
Abstract: Synucleinopathies, such as Parkinson’s disease (PD), are characterized by the intracellular accumulation of misfolded and aggregated alpha-synuclein (α-syn), which is mostly phosphorylated (p-α-syn). This aggregated α-syn can spread throughout the brain in a prion-like manner through templated misfolding. Small extracellular vesicles, like exosomes, are one mechanism by which α-syn is transferred intercellularly. First, we found that primary neurons develop progressive p-α-syn pathology following exposure to brain exosomes isolated from synucleinopathy-affected mice. We then tested a potential therapeutic, VH14-PEST, to reduce the spread of α-syn and its intracellular aggregation in a seeded-synucleinopathy cellular model. VH14-PEST is a single-domain antibody fragment (nanobody) targeting α-syn and previously shown to reduce its accumulation. Upon intracellular expression in primary neurons, VH14-PEST significantly reduced p-α-syn up to 14 days. This work demonstrates that exosomes can transport pathological α-syn contributing to its prion-like spread, and that reducing α-syn with nanobody expression is helpful in mitigating α-syn pathology.
Source: TSpace (University of Toronto)
Author: Armstrong, Sabrina
Institution: University of Toronto
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7133014611
